本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1999/8/111 分钟阅读
Agency Information Collection Activities; Announcement of OMB Approval; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →